Food and Drug Administration CDER In vitro release tests for topical dermatological products (U01) Deadline: July 1, 2013 http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-13-016.html Bioequivalence of topical dermatological products has been a longstanding challenge to FDA. An in vitro release test could be used as part of the bioequivalence evaluation of topical products. This project will investigate in vitro - in vivo correlations of topical dermatological products. The goal is to identity in vitro release test conditions that are best correlated with in vivo performance. In vivo performance could be assessed by human pharmacokinetic (PK) data, human microdialysis data or other proposed source. Alternative Research and Development Foundation Deadline: Notification April 23, Application April 30, 2013 http://ardf-online.org The mission of the Alternatives Research and Development Foundation is to fund and promote the development, validation and adoption of non-animal methods in biomedical research, product testing and education. Kristie Sullivan Secretary, ASCCT www.ascctox.org This email was sent to members of the American Society for Cellular and Computational Toxicology. Learn more at www.ascctox.org. To post, send to ascct@xxxxxxxxxxxxx. To unsubscribe, send an email with the subject line "unsubscribe" to ksullivan@xxxxxxxxxxx. To view an archive of list emails, visit www.freelists.org/archive/ascct.